Flagship Pioneering Fund VII, L.P.'s Net Worth

-$12.2 Million

Estimate Recalculated May 17, 2024 07:26PM EST

Who is Flagship Pioneering Fund VII, L.P.?

Flagship Pioneering Fund VII, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Evelo Biosciences, Inc., Seres Therapeutics, Inc., and Omega Therapeutics, Inc..

SEC CIK

Flagship Pioneering Fund VII, L.P.'s CIK is 0001805916

Past Insider Trading and Trends

2023 was Flagship Pioneering Fund VII, L.P.'s most active year for acquiring shares with 3 total transactions. Flagship Pioneering Fund VII, L.P.'s most active month to acquire stocks was the month of June. 2023 saw Flagship Pioneering Fund VII, L.P. paying a total of $12,499,999.05 for 5,411,255 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Evelo Biosciences, Inc. (EVLO) Snapshot price: $0.04

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+366.75%
5.41M
$2.31
$12,499,999.05
6.89M
Jul 11
Form 3
—
0
—
—
0
No matching records found

Seres Therapeutics, Inc. (MCRB) Snapshot price: $1.035

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Omega Therapeutics, Inc. (OMGA) Snapshot price: $3.61

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Sana Biotechnology, Inc. (SANA) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found